Suppr超能文献

抗生素增效作为对抗细菌病原体大环内酯类耐药性的一种有前景的策略。

Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens.

作者信息

Paul Deepjyoti, Chawla Meenal, Ahrodia Taruna, Narendrakumar Lekshmi, Das Bhabatosh

机构信息

Functional Genomics Laboratory, Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, Faridabad 121001, India.

出版信息

Antibiotics (Basel). 2023 Dec 11;12(12):1715. doi: 10.3390/antibiotics12121715.

Abstract

Antibiotics, which hit the market with astounding impact, were once called miracle drugs, as these were considered the ultimate cure for infectious diseases in the mid-20th century. However, today, nearly all bacteria that afflict humankind have become resistant to these wonder drugs once developed to stop them, imperiling the foundation of modern medicine. During the COVID-19 pandemic, there was a surge in macrolide use to treat secondary infections and this persistent use of macrolide antibiotics has provoked the emergence of macrolide resistance. In view of the current dearth of new antibiotics in the pipeline, it is essential to find an alternative way to combat drug resistance. Antibiotic potentiators or adjuvants are non-antibacterial active molecules that, when combined with antibiotics, increase their activity. Thus, potentiating the existing antibiotics is one of the promising approaches to tackle and minimize the impact of antimicrobial resistance (AMR). Several natural and synthetic compounds have demonstrated effectiveness in potentiating macrolide antibiotics against multidrug-resistant (MDR) pathogens. The present review summarizes the different resistance mechanisms adapted by bacteria to resist macrolides and further emphasizes the major macrolide potentiators identified which could serve to revive the antibiotic and can be used for the reversal of macrolide resistance.

摘要

抗生素以惊人的影响力进入市场,曾被称为神奇药物,因为在20世纪中叶,它们被视为治疗传染病的终极疗法。然而如今,几乎所有困扰人类的细菌都对这些曾经用于对抗它们的神奇药物产生了耐药性,危及现代医学的根基。在新冠疫情期间,用于治疗继发感染的大环内酯类药物的使用激增,而这种对大环内酯类抗生素的持续使用引发了大环内酯类耐药性的出现。鉴于目前正在研发的新抗生素匮乏,找到对抗耐药性的替代方法至关重要。抗生素增效剂或佐剂是一类非抗菌活性分子,与抗生素联合使用时可增强其活性。因此,增强现有抗生素的效力是应对和最小化抗菌药物耐药性(AMR)影响的一种有前景的方法。几种天然和合成化合物已证明在增强大环内酯类抗生素对多重耐药(MDR)病原体的效力方面具有有效性。本综述总结了细菌为抵抗大环内酯类药物而采用的不同耐药机制,并进一步强调了已确定的主要大环内酯类增效剂,这些增效剂可用于恢复抗生素的效力,并可用于逆转大环内酯类耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3947/10740890/25e8ad476280/antibiotics-12-01715-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验